| P50 | author | Dennis W. Dickson | Q30504740 |
| | David S Knopman | Q63967707 |
| | Bradley F Boeve | Q67501037 |
| | Jonathan Graff-Radford | Q83230600 |
| | Kejal Kantarci | Q83230766 |
| | Tanis J Ferman | Q91521563 |
| | Val J. Lowe | Q107200019 |
| | Jeffrey L Gunter | Q107209317 |
| | Scott A. Przybelski | Q114336657 |
| | Timothy G Lesnick | Q114336660 |
| | Matthew L Senjem | Q30505707 |
| | Clifford Jack | Q30505709 |
| | Melissa E. Murray | Q42734330 |
| | Glenn E. Smith | Q46205917 |
| | Ronald C. Petersen | Q56839853 |
| P2860 | cites work | 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment | Q24648319 |
| | Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 |
| | Cortical circuits for the control of attention | Q27006706 |
| | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
| | Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia | Q29397661 |
| | Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 |
| | The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 |
| | The precuneus: a review of its functional anatomy and behavioural correlates | Q29615024 |
| | Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Q29620245 |
| | Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. | Q67234444 |
| | Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study | Q67532800 |
| | Predictors of survival in dementia with lewy bodies and Parkinson dementia | Q81436127 |
| | Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank | Q33445409 |
| | Low sensitivity in clinical diagnoses of dementia with Lewy bodies | Q33729642 |
| | Comparative evaluation of MR-based partial-volume correction schemes for PET. | Q33885188 |
| | Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease | Q34999303 |
| | Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies | Q35183572 |
| | Multimodality imaging characteristics of dementia with Lewy bodies | Q35785744 |
| | Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies | Q36124416 |
| | Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies | Q36146930 |
| | Time until nursing home admission in people with mild dementia: comparison of dementia with Lewy bodies and Alzheimer's dementia | Q39367378 |
| | Antemortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies | Q42080626 |
| | Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. | Q42454450 |
| | Correlations of synaptic and pathological markers with cognition of the elderly | Q42478788 |
| | Improved Visual Hallucination by Donepezil and Occipital Glucose Metabolism in Dementia with Lewy Bodies: The Osaki-Tajiri Project | Q42821360 |
| | The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies | Q43275689 |
| | Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation | Q43738764 |
| | Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. | Q46597682 |
| | Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia | Q46780549 |
| | Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 |
| | Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. | Q48279657 |
| | Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. | Q48527481 |
| | Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography | Q48590317 |
| | DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging | Q48604179 |
| | Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease | Q48671019 |
| | Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. | Q48696767 |
| | Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography | Q49041969 |
| | Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. | Q50794030 |
| | Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. | Q53231400 |
| | Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. | Q53264799 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| | dementia with Lewy bodies | Q101245788 |
| P304 | page(s) | 801-809 | |
| P577 | publication date | 2014-07-23 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Dementia with Lewy bodies: basis of cingulate island sign | |
| P478 | volume | 83 | |